printemailclick to share buttonfacebooktwitterlinkedin
What's New in the Past 6 Months

Links to Newly Approved PEBC Guidelines and Other Reports

Please use the left navigation buttons to access the full versions of the PEBC Evidence-based Series and other reports

September 2017

  • Treatment of Patients with Stage III (N2 or N3) Non-Small Cell Lung Cancer
    Guideline 7-3 Version 3
    Status: CURRENT: September 2017
  • Breast Screening for Survivors of Breast Cancer
    Evidence Summary 15-15: September 2017
    Status: CURRENT

August 2017

  • Cancer Care Ontario Sequence Variants in Hereditary Cancers Guideline: An Endorsement of the 2015 Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
    Guideline Endorsement MOTAC-5
    Status: CURRENT

July 2017

  • Systemic Therapy for Recurrent Epithelial Ovarian Cancer
    Guideline 4-3 Version 4: July 2017
    Status: CURRENT

May 2017

  • Comparison of PET/CT and PET/MR Imaging in Oncology
    Evidence Summary PET 16: April 2016
  • PET Imaging in Paraneoplastic Neurological Symptoms
    Evidence Summary PET 18: May 2017
  • The Use of Targeted Therapies in Patients with Inoperable Locally Advanced or Metastatic Renal Cell Cancer: Updated Guideline 2017
    Guideline 3-8-4 Version 2: May 2017
    Status: CURRENT
  • PET Six-Month Monitoring Report 2016-2
    Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines: July 2016 to December 2016

April 2017

  • Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update
    Guideline 7-A-2016-3
    Status: CURRENT
    This clinical practice guideline is an ASCO-CCO collaboration, produced by a joint expert panel convened by the ASCO Clinical Practice Guidelines Committee and the CCO Program In Evidence-based Care

    Program in Evidence-Based Care (PEBC)
    McMaster University, Juravinski Site
    G Wing, 2nd Floor
    711 Concession Street
    Hamilton, Ontario, Canada
    L8V 1C3

    Phone: 905.527.4322 ext. 42822
    Fax: 905.526.6775
Last modified: Fri, Sep 15, 2017
cancer care ontario | action cancer ontario   620 University Avenue Toronto Ontario, Canada M5G 2L7   Phone: 416.971.9800 Fax: 416.971.6888

Please help improve the quality of our website by answering 10 brief questions in our online survey. Would you like to participate?